2016-03-11T00:00:00.000-05:00
human life,0.873275
ischemic stroke,-0.442075
lead product candidate,0.249268
current price,0.580728
current clinical development,-0.805417
52-week low,-0.753015
price objective,0.580728
clinical trials,-0.462145
price target,0.324105
Athersys Inc.,0.60381
research analysts,-0.214357
Zacks Investment Research‘s,0.580728
InvestorPlace Broker Center,0.555736
multiple disease indications,-0.469047
biopharmaceutical company,0.59869
international biotechnology company,0.253411
SEC website,0.489784
Zacks Investment Research,0.319723
personal trading style,0.598412
myocardial infarction,-0.40233
Athersys,-0.231454
therapeutic product candidates,0.873275
5HT2c receptor agonist,-0.462145
average price,0.0120395
shares,-0.31459
company’s stock,0.324105
concise daily summary,0.458426
Marketbeat.com reports,-0.286174
stock broker,0.245696
potential upside,0.580728
nervous system disorders,-0.550834
active pharmaceutical product,-0.550834
COO William Lehmann,0.252791
